Dr Dogra

Dr Dogra, MD & CEO of Care Ratings, said that the alliance is particularly beneficial as JCR is among the 10 agencies recognised by the US Securities and Exchange Commission and also by few European countries.

See surveillance income growing at 8% in H2: CARE

The company's net profit fell 27.77 percent to Rs 37.85 crore during the second quarter ended September 30. The ratings agency had clocked a net profit of Rs 52.41 crore during the corresponding period of previous fiscal

Govt okays composite foreign investment cap for FDI, FII

Composite caps have been suggested for agriculture, manufacturing, airports, real estate, telecom and other sectors.

Kalpyto's performance will surprise market this year: CARE

In an interview to CNBC-TV18, DR Dogra, MD & CEO, CARE Ratings, discusses the company's fourth quarter earnings and its future outlook.

Post IDBI stake sale, LIC our largest shareholder: CARE

IDBI has recently sold 10 percent stake in CARE Ratings possibly to LIC which is now the largest shareholder.

H2 will be better than H1; higher credit growth a plus:CARE

DR Dogra, MD and CEO, CARE Ratings says the company had a good quarter on stabilising credit growth. He adds that the second half earnings of the fiscal year will be better than the first half.

Corporate rating upgrades may continue going forward: CARE

For every downgrade there have been 1.25 upgrades in Q2FY15, says DR Dogra, MD & CEO of Care Ratings

Rating on Bhushan Steel was cut in March 2014: CARE Ratings

Analysts believe widening gap between company‘s financial ratio and credit rating raises questions over accuracy. However, rating agencies look at many parameters such as industry risk, financial risk and business specific risks apart from leverage, says DR Dogra of CARE Ratings.

Hope to deliver better results in next 3 quarters: CARE

CARE would be conducting surveillance for more than 5,000 companies, which will certainly its topline in good order, says MD & CEO DR Dogra.

Saw addition of 1725 new clients in 9-months: Care Ratings

In an interview to CNBC-TV18, Dr Dogra, MD & CEO, CARE Ratings said despite challenging environment, the total number of assignments were over 4,000. Further more he said, “ The company added around 1,725 new clients during the 9 month period of which 626 were added during Q3 of FY13.”

On top due to focus on cost-efficiency, research: CARE

DR Dogra, CEO, CARE Ratings explains to CNBC-TV18 that the agency's focus on cost-efficiency and research has enabled it to keep the competition at bay and cater to the increasing needs of a burgeoning economy.

Care Ratings fixes price band of Rs 700-750/share for IPO

Credit Analysis and Research Ltd or Care Ratings has fixed the price band for its initial public offer (IPO) of shares at Rs.700-750 a share, said the company management on Monday. The share sale will open for subscription on December 7 and will close on December 11.